Filing Details
- Accession Number:
- 0001179110-12-017082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-06 20:20:19
- Reporting Period:
- 2012-12-06
- Filing Date:
- 2012-12-06
- Accepted Time:
- 2012-12-06 20:20:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1005201 | Depomed Inc | DEPO | Pharmaceutical Preparations (2834) | 943229046 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1420228 | Md Michael Sweeney | 7999 Gateway Boulevard, Suite 300 Newark CA 94560 | Cmo And Vp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-12-06 | 1,418 | $5.77 | 5,315 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares sold for payment of payroll tax withholdings in connection with vesting of restricted stock. The sales reported in this Form 4 were sold pursuant to a rule 10b5-1 trading plan adopted by the reporting person in September 2012.
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.75 to $5.79. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
- Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.